Latest Period
Q2 2026
Security Snapshot
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) Institutional Ownership
CUSIP: 67577R102
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
103
Shares (Excl. Options)
57,511,923
Price
$4.11
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- IRD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 57,511,923
- Total 13F value
- $236,380,475
- Portfolio coverage rank
- 0%
- Share change
- +12,076,216
- Value change
- +$48,003,889
- Number of holders
- 103
- Shares outstanding
- 83,247,726
- SEC-reported price per share
- $3.47
- Insider filing price
- $3.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 67577R102.
- 103 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 77 to 103 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $201,532,694 to $236,380,475.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 103 institutions filings for Q2 2026.
Security key
67577R102
Latest holder period
Q2 2026
13F holders
103
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
IRD full holder history
Opus Genetics, Inc. SEC filings
Opus Genetics, Inc. company facts
Opus Genetics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 67577R102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
IRD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% | 0% | $37,858,211 | +$1,654,616 | 9,233,710 | +4.6% | Perceptive Advisors LLC | 30 Jun 2026 |
| Caligan Partners LP | 7.3% | -13% | $24,916,044 | +$8,430 | 6,077,084 | +0.03% | Caligan Partners LP | 30 Jun 2026 |
| Adage Capital Management, L.P. | 8.5% | $29,666,493 | 6,029,775 | Adage Capital Management, L.P. | 31 Mar 2026 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 6.6% | -7.7% | $22,468,861 | +$1,516,332 | 5,480,210 | +7.2% | BALYASNY ASSET MANAGEMENT L.P. | 30 Jun 2026 |
| Nantahala Capital Management, LLC | 6.5% | -35% | $23,808,987 | -$11,238,663 | 4,839,225 | -32% | Nantahala Capital Management, LLC | 31 Mar 2026 |
| Foundation Fighting Blindness Retinal Degeneration Fund | 4.7% | -42% | $17,709,439 | -$7,939,000 | 3,792,171 | -31% | Foundation Fighting Blindness Retinal Degeneration Fund | 18 May 2026 |
| BIOS Fund III, LP | 4.5% | $18,122,471 | 3,683,429 | AARON G.L. FLETCHER | 12 May 2026 |
As of 30 Jun 2026, 103 institutional investors reported holding 57,511,923 shares of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD). This represents 69% of the company’s total 83,247,726 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
64%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Caligan Partners LP | 7.3% | 6,077,084 | +0.03% | 1.2% | $24,976,815 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.2% | 6,029,775 | 0% | 0.03% | $24,782,375 |
| BIOS Capital Management, LP | 4.4% | 3,683,429 | 0% | 36% | $15,138,893 |
| BlackRock, Inc. | 3.7% | 3,116,487 | +2009% | 0% | $12,808,762 |
| Balyasny Asset Management L.P. | 3.7% | 3,087,866 | +14% | 0.02% | $12,691,129 |
| Nantahala Capital Management, LLC | 3.7% | 3,061,359 | +82% | 0.76% | $12,582,185 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 2,958,683 | +21% | 0% | $12,160,187 |
| Boxer Capital Management, LLC | 3.4% | 2,815,000 | +25% | 0.87% | $11,569,650 |
| Trails Edge Capital Partners, LP | 3.3% | 2,743,658 | +449% | 1.8% | $11,276,434 |
| MILLENNIUM MANAGEMENT LLC | 2.8% | 2,302,101 | -12% | 0.01% | $9,461,635 |
| GREAT POINT PARTNERS LLC | 2.4% | 1,970,187 | +507% | 1.9% | $8,097,469 |
| MARSHALL WACE, LLP | 2.3% | 1,945,609 | -16% | 0.01% | $7,996,453 |
| ADAR1 Capital Management, LLC | 2.1% | 1,783,781 | -3.5% | 0.35% | $7,331,340 |
| GOLDMAN SACHS GROUP INC | 1.8% | 1,527,229 | +367% | 0% | $6,276,912 |
| Woodline Partners LP | 1.7% | 1,434,713 | +6% | 0.02% | $5,896,670 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,367,712 | +154% | 0% | $5,622,928 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.4% | 1,189,515 | +0.03% | 0.09% | $4,888,907 |
| Opaleye Management Inc. | 1.4% | 1,125,000 | 0% | 0.42% | $4,623,750 |
| SummitTX Capital, L.P. | 1.2% | 1,007,351 | 0.11% | $4,140,213 | |
| STATE STREET CORP | 0.95% | 790,136 | +295% | 0% | $3,247,459 |
| Bleichroeder LP | 0.89% | 736,842 | 0% | 0.54% | $3,028,421 |
| UBS Group AG | 0.82% | 683,895 | +165% | 0% | $2,810,808 |
| CITADEL ADVISORS LLC | 0.8% | 665,662 | +451% | 0% | $2,735,871 |
| MORGAN STANLEY | 0.56% | 464,900 | +1076% | 0% | $1,910,739 |
| NORTHERN TRUST CORP | 0.53% | 442,154 | +368% | 0% | $1,817,253 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 57,511,923 | $236,380,475 | +$48,003,889 | $4.11 | 103 |
| 2026 Q1 | 44,292,526 | $201,532,694 | +$79,524,140 | $4.55 | 77 |
| 2025 Q4 | 27,812,069 | $55,903,061 | +$17,653,005 | $2.01 | 58 |
| 2025 Q3 | 19,026,274 | $31,911,867 | +$2,765,658 | $1.65 | 46 |
| 2025 Q2 | 17,503,196 | $16,482,508 | +$2,741,389 | $0.94 | 43 |
| 2025 Q1 | 14,560,311 | $14,686,745 | +$11,049,669 | $0.98 | 46 |
| 2024 Q4 | 3,678,848 | $4,378,207 | +$106,956 | $1.19 | 42 |
| 2024 Q3 | 2,531,596 | $3,315,513 | -$283,780 | $1.31 | 37 |
| 2024 Q2 | 2,696,097 | $4,126,103 | -$1,250,857 | $1.53 | 37 |
| 2024 Q1 | 3,374,307 | $6,780,798 | -$925,460 | $2.01 | 48 |
| 2023 Q4 | 3,712,141 | $11,173,334 | -$177,249 | $3.01 | 48 |
| 2023 Q3 | 3,768,545 | $12,624,748 | +$43,437 | $3.35 | 50 |
| 2023 Q2 | 3,675,838 | $15,952,413 | +$1,001,477 | $4.34 | 49 |
| 2023 Q1 | 3,457,077 | $12,962,551 | +$1,457,390 | $3.75 | 40 |
| 2022 Q4 | 3,099,588 | $10,946,085 | +$1,241,957 | $3.53 | 34 |
| 2022 Q3 | 2,825,667 | $5,686,000 | +$828,901 | $2.01 | 33 |
| 2022 Q2 | 2,407,242 | $4,623,000 | +$385,937 | $1.92 | 35 |
| 2022 Q1 | 2,052,047 | $6,623,000 | -$430,212 | $3.23 | 33 |
| 2021 Q4 | 2,169,473 | $8,073,000 | +$1,421,030 | $3.73 | 32 |
| 2021 Q3 | 1,679,507 | $8,621,000 | +$3,116,790 | $5.15 | 26 |
| 2021 Q2 | 1,038,443 | $5,482,000 | +$532,990 | $5.28 | 28 |
| 2021 Q1 | 912,180 | $5,265,087 | -$7,635,114 | $5.81 | 21 |
| 2020 Q4 | 2,209,512 | $14,469,013 | +$1,044,013 | $6.52 | 9 |